Balyasny Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-713,026
| Closed | -$36.8M | – | 3055 |
|
|
2022
Q3 | $36.8M | Buy |
+713,026
| New | +$36.8M | 0.11% | 183 |
|
|
2018
Q3 | – | Sell |
-11,125
| Closed | -$147K | – | 1874 |
|
|
2018
Q2 | $147K | Buy |
+11,125
| New | +$147K | ﹤0.01% | 1502 |
|
|
2016
Q2 | – | Sell |
-955,134
| Closed | -$2.38M | – | 1301 |
|
|
2016
Q1 | $2.38M | Sell |
955,134
-676,192
| -41% | -$1.68M | 0.01% | 496 |
|
|
2015
Q4 | $13.2M | Sell |
1,631,326
-699,874
| -30% | -$5.67M | 0.09% | 277 |
|
|
2015
Q3 | $14.1M | Buy |
2,331,200
+85,925
| +4% | +$520K | 0.1% | 231 |
|
|
2015
Q2 | $18.5M | Buy |
2,245,275
+377,678
| +20% | +$3.11M | 0.11% | 196 |
|
|
2015
Q1 | $14.1M | Buy |
1,867,597
+57,141
| +3% | +$431K | 0.11% | 223 |
|
|
2014
Q4 | $12.4M | Sell |
1,810,456
-953,771
| -35% | -$6.51M | 0.11% | 208 |
|
|
2014
Q3 | $12.4M | Buy |
2,764,227
+10,577
| +0.4% | +$47.6K | 0.1% | 192 |
|
|
2014
Q2 | $16.1M | Buy |
2,753,650
+463,229
| +20% | +$2.71M | 0.18% | 117 |
|
|
2014
Q1 | $15.2M | Buy |
2,290,421
+1,131,808
| +98% | +$7.5M | 0.17% | 127 |
|
|
2013
Q4 | $6.71M | Buy |
1,158,613
+676,213
| +140% | +$3.92M | 0.09% | 225 |
|
|
2013
Q3 | $2.68M | Buy |
+482,400
| New | +$2.68M | 0.04% | 329 |
|